182 related articles for article (PubMed ID: 24123289)
1. Optimal auxiliary-covariate-based two-phase sampling design for semiparametric efficient estimation of a mean or mean difference, with application to clinical trials.
Gilbert PB; Yu X; Rotnitzky A
Stat Med; 2014 Mar; 33(6):901-17. PubMed ID: 24123289
[TBL] [Abstract][Full Text] [Related]
2. Calibration weighted estimation of semiparametric transformation models for two-phase sampling.
Fong Y; Gilbert P
Stat Med; 2015 May; 34(10):1695-707. PubMed ID: 25648332
[TBL] [Abstract][Full Text] [Related]
3. Analysis of two-phase sampling data with semiparametric additive hazards models.
Sun Y; Qian X; Shou Q; Gilbert PB
Lifetime Data Anal; 2017 Jul; 23(3):377-399. PubMed ID: 26995733
[TBL] [Abstract][Full Text] [Related]
4. Hypothesis tests for stratified mark-specific proportional hazards models with missing covariates, with application to HIV vaccine efficacy trials.
Sun Y; Qi L; Yang G; Gilbert PB
Biom J; 2018 May; 60(3):516-536. PubMed ID: 29488249
[TBL] [Abstract][Full Text] [Related]
5. Semiparametric methods for multiple exposure mismeasurement and a bivariate outcome in HIV vaccine trials.
Golm GT; Halloran ME; Longini IM
Biometrics; 1999 Mar; 55(1):94-101. PubMed ID: 11318183
[TBL] [Abstract][Full Text] [Related]
6. Combining biomarkers for classification with covariate adjustment.
Kim S; Huang Y
Stat Med; 2017 Jul; 36(15):2347-2362. PubMed ID: 28276080
[TBL] [Abstract][Full Text] [Related]
7. Design and estimation for evaluating principal surrogate markers in vaccine trials.
Huang Y; Gilbert PB; Wolfson J
Biometrics; 2013 Jun; 69(2):301-9. PubMed ID: 23409839
[TBL] [Abstract][Full Text] [Related]
8. Analyzing cellular immunogenicity in vaccine clinical trials: a new statistical method including non-specific responses for accurate estimation of vaccine effect.
Lhomme E; Hejblum BP; Lacabaratz C; Wiedemann A; Lelièvre JD; Levy Y; Thiébaut R; Richert L
J Immunol Methods; 2020 Feb; 477():112711. PubMed ID: 31809708
[TBL] [Abstract][Full Text] [Related]
9. Best linear inverse probability weighted estimation for two-phase designs and missing covariate regression.
Wang CY; Dai J
Stat Med; 2019 Jul; 38(15):2783-2796. PubMed ID: 30908669
[TBL] [Abstract][Full Text] [Related]
10. Missing data approaches for probability regression models with missing outcomes with applications.
Qi L; Sun Y
J Stat Distrib Appl; 2014; 1():. PubMed ID: 26900543
[TBL] [Abstract][Full Text] [Related]
11. Estimation of conditional cumulative incidence functions under generalized semiparametric regression models with missing covariates, with application to analysis of biomarker correlates in vaccine trials.
Sun Y; Heng F; Lee U; Gilbert PB
Can J Stat; 2023 Mar; 51(1):235-257. PubMed ID: 36937899
[TBL] [Abstract][Full Text] [Related]
12. Augmented designs to assess immune response in vaccine trials.
Follmann D
Biometrics; 2006 Dec; 62(4):1161-9. PubMed ID: 17156291
[TBL] [Abstract][Full Text] [Related]
13. Nonparametric Regression With Missing Outcomes Using Weighted Kernel Estimating Equations.
Wang L; Rotnitzky A; Lin X
J Am Stat Assoc; 2010 Sep; 105(491):1135-1146. PubMed ID: 23144520
[TBL] [Abstract][Full Text] [Related]
14. Leveraging auxiliary data to improve precision in inverse probability-weighted analyses.
Zalla LC; Yang JY; Edwards JK; Cole SR
Ann Epidemiol; 2022 Oct; 74():75-83. PubMed ID: 35940394
[TBL] [Abstract][Full Text] [Related]
15. Mark-specific hazard ratio model with multivariate continuous marks: an application to vaccine efficacy.
Juraska M; Gilbert PB
Biometrics; 2013 Jun; 69(2):328-37. PubMed ID: 23421613
[TBL] [Abstract][Full Text] [Related]
16. Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content.
Orellana L; Rotnitzky A; Robins JM
Int J Biostat; 2010; 6(2):Article 8. PubMed ID: 21969994
[TBL] [Abstract][Full Text] [Related]
17. Semiparametric estimation exploiting covariate independence in two-phase randomized trials.
Dai JY; LeBlanc M; Kooperberg C
Biometrics; 2009 Mar; 65(1):178-87. PubMed ID: 18479485
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the time-varying Cox model for the cause-specific hazard functions with missing causes.
Heng F; Sun Y; Hyun S; Gilbert PB
Lifetime Data Anal; 2020 Oct; 26(4):731-760. PubMed ID: 32274677
[TBL] [Abstract][Full Text] [Related]
19. Analysis of case-cohort designs with binary outcomes: Improving efficiency using whole-cohort auxiliary information.
Noma H; Tanaka S
Stat Methods Med Res; 2017 Apr; 26(2):691-706. PubMed ID: 25348675
[TBL] [Abstract][Full Text] [Related]
20. Efficient and robust method for comparing the immunogenicity of candidate vaccines in randomized clinical trials.
Gilbert PB; Sato A; Sun X; Mehrotra DV
Vaccine; 2009 Jan; 27(3):396-401. PubMed ID: 19022314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
